Skip to content

Circadian Changes of the Hypothalamic Activity in Patients Suffering From Cluster Headache

Circadian Changes of the Hypothalamic Activity in Patients Suffering From Cluster Headache

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04409977
Enrollment
60
Registered
2020-06-01
Start date
2019-06-26
Completion date
2020-06-30
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cluster Headache

Keywords

Primary Headache, Trigeminal autonomic cephalgia, functional connectivity

Brief summary

Cluster headache attacks do not occur randomly throughout the day, but have a clear circadian rhythmicity. The aim of this study is to investigate circadian changes of the brain, the autonomic nervous system and pain processing systems.

Detailed description

Cluster headache attacks do not occur randomly throughout the day, but have a clear circadian rhythmicity. The aim of this study is to investigate circadian changes in the functional connectivity, spectroscopy, iron deposition and perfusion of the brain. In addition, we plan to investigate circadian changes in the pain threshold of the brain using quantitative sensory testing (QST). Finally, we will investigate changes in the autonomic nervous system measuring the pupillary response.

Interventions

DIAGNOSTIC_TESTMRI examination

Patient will be scanned in the MRI twice, once at noon (+/- 1 hour), once at 1 a.m. (+/- 1 hour). The investigators will search for any changes in functional connectivity, particular regarding the connection between the hypothalamus and pain-processing networks.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of cluster headache (CH) may enter the patient group, patients not suffering from CH may enter the control group. * knowledge of the german language suffices to understand the information sheet and consent form * having read, understood and signed the consent form

Exclusion criteria

* Pregnancy * contraindications for the MRI scan (particularly metal splinters, ferromagnetic devices and implants) * claustrophobia * obesity (MRI \> 35 kg/m2) * shift working (last night shift must date back more than one week) * jet lag (last travel over more than two time zones must date back more than one week)

Design outcomes

Primary

MeasureTime frameDescription
Circadian rhythmicity of the functional connectivity of the brainMeasurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.Changes from baseline in functional connectivity of the brain using whole-brain fMRI

Secondary

MeasureTime frameDescription
Circadian rhythmicity of the pain thresholdMeasurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.Changes from baseline of the pain threshold in the face using quantitative sensory testing (QST)
Circadian changes in the perfusion of the brain.Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.Changes from baseline in perfusion of the brain using Arterial Spin Labeled MRI Perfusion Imaging and vascular space occupancy sequences
Circadian rhythmicity of the autonomic systemMeasurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.Changes from baseline in the pupillary response (measured using pupillometry)
Circadian rhythmicity of the spectroscopy of the hypothalamusMeasurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.Changes from baseline in the spectroscopy of the hypothalamus

Countries

Switzerland

Contacts

Primary ContactHeiko Pohl, MD
heiko.pohl@usz.ch+41 44 255 1856

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026